"I don't think we have enough data to reach that conclusion yet." Patients who lose weight with GLP-1 RAs can experience a "big boost" in confidence, as well as a change in personality and even relationships, according to Ghanem
Retatrutide, on the other hand, is a triple-agonist that targets GLP-1, GIP, and Glucagon receptors simultaneously
The clinical principle most obesity-medicine specialists apply: escalate to the lowest dose that produces consistent, expected weight loss with manageable side effects
With digital lifestyles contributing to erratic circadian rhythms, inconsistent eating patterns, and hormone disruptions, the emergence of nasal-delivery peptides adds a much-needed layer of convenience and consistency
Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats